Home > Healthcare > Biotechnology > Biotechnology Instruments Market
Biotechnology Instruments Market size was valued USD 61.1 billion in 2022 and is expected to grow at a CAGR of over 4.4% between 2023 and 2032, driven by the increasing demand for precision diagnostics, advances in molecular biologics, genomics, and the need for advanced analytical techniques.
Additionally, the rising prevalence of chronic conditions such as infectious diseases, cardiovascular diseases, diabetes, sepsis, and cancer is expected to propel the market growth. For instance, according to Cancer Atlas, cancer cases are projected to increase from 18 million cases in 2018 to an estimated 29 million by 2040. Therefore, the growing burden of cancer has surged the demand for effective diagnostics techniques. Thus, advances in biotechnology industry offer optimism for early cancer diagnostics and treatment, with biotechnological techniques providing a growth avenue for the market.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Biotechnology Instruments Market Size in 2022: | USD 61.1 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 4.4% |
2032 Value Projection: | USD 96.1 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 280 |
Tables, Charts & Figures: | 429 |
Segments covered: | Product, Application, End-user, & Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Biotechnology instruments are the specialized systems employed in the field of biotechnology for various applications. These instruments play a crucial role in operating biological systems, analysing biomolecules, and conducting experiments to advance biotechnological research.